openPR Logo
Press release

mRNA Synthesis and Manufacturing Services Market Investment Opportunities and Forecast 2026 to 2035

03-31-2026 11:52 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

mRNA Synthesis and Manufacturing Services Market

mRNA Synthesis and Manufacturing Services Market

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global mRNA Synthesis and Manufacturing Services Market (by Type of Industry (Therapeutics and Vaccine Developers, CDMO Organizations, Custom Synthesis/Other Service Providers), Applications (Infectious Disease Vaccines, Other Vaccines, Therapeutics and Others), Scale of Operation (Research / Preclinical, Clinical, Commercial))- Market Outlook and Industry Analysis 2034"

Global mRNA Synthesis and Manufacturing Services Market Size is valued at USD 958.52 Mn in 2024 and is predicted to reach USD 2,294.90 Mn by the year 2034 at a 7.7% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1185

Messenger RNA (mRNA) molecules are single-stranded nucleic acids transcribed from DNA that play a fundamental role in gene expression by directing the synthesis of specific proteins within cells. Owing to their adaptability and versatility, mRNA-based platforms have become a key foundation for the development of both therapeutic and prophylactic vaccines targeting a broad range of infectious and chronic diseases.

Compared to conventional pharmaceutical approaches, mRNA vaccines demonstrate higher immunogenicity, improved efficacy, and more efficient and cost-effective manufacturing processes. The widespread deployment of mRNA-based COVID-19 vaccines, followed by regulatory approvals for additional indications, has significantly increased the demand for mRNA production capabilities.

Beyond vaccines, mRNA-based therapeutics hold substantial promise in addressing complex disease areas, including infectious diseases, metabolic and genetic disorders, oncology, and cardiovascular and cerebrovascular conditions. These therapies do not carry the risk of causing infection or insertional mutagenesis, offering a distinct advantage over traditional gene therapy approaches. Furthermore, mRNA enables sustained protein expression through continuous translation, resulting in enhanced therapeutic effectiveness compared to conventional protein- or peptide-based treatments.

The expansion of the mRNA synthesis and manufacturing services sector is being driven by the rising prevalence of rare diseases, such as propionic acidemia, methylmalonic acidemia, glycogen storage disorders, and alongside increasing cases of metabolic and immunological disorders. In addition, the growing incidence of chronic diseases, including cancer, cardiovascular disorders, pulmonary conditions, and chronic kidney disease, is further contributing to market demand. Advances in biopharmaceutical manufacturing technologies are prompting service providers to expand production capacity and infrastructure to meet the growing needs of this evolving therapeutic landscape.

Market growth is further supported by an increasing number of clinical trials focused on oncology and infectious diseases, along with rising investments, strategic partnerships, mergers, and intensified research and development activities. For instance, in April 2021, the mRNA company Arcturus Therapeutics entered into a joint venture with Japan-based Axcelead, Inc. to establish a new entity in Chiba Prefecture and initiate the development of a manufacturing facility in Minamisoma City, Fukushima Prefecture. Such strategic initiatives are expected to strengthen industry capabilities and support the continued expansion and adoption of mRNA technologies in the coming years.

Add our site to Google Preferred Sources for quality content: https://google.com/preferences/source?q=insightaceanalytic.com

The growth of the mRNA synthesis and manufacturing services market is being constrained by the limited availability of manufacturing processes that are scalable, cost-efficient, and sustainable. In addition, prolonged regulatory approval timelines and extended clinical trial processes are expected to impede market expansion over the forecast period.

In North America, market growth is supported by substantial funding allocated to research and development, the expansion of government initiatives focused on RNA-based therapeutics, and a rising number of clinical studies. These factors collectively contribute to the region's continued leadership in the mRNA synthesis and manufacturing services market.

Some of the significant market players in the mRNA synthesis and manufacturing services market are eTheRNA (Etherna Immunotherapies), Eurogentec, Aldevron, biosynthesis, Biomay, Jena Biosciences, APExBIO, TriLink BioTechnologies, CELLSCRIPT, Thermo Fisher Scientific, New England Biolabs, BioNTech (Pfizer), Translate Bio, CureVac, Moderna, Ethris (AstraZeneca), Kernal Biologics, Silence Therapeutics, In-Cell-Art, Anima Biotch, H3 Biomedicine Inc., Tiba Biotechnology, Arcturus Therapeutics, Ionis Pharmaceuticals, Inc., Stemirna Therapeutics Co., Ltd., eFFECTOR Therapeutics, Inc., Ziphius Therapeutics NV, miRagen Therapeutics, Inc., RNAimmune (Sirnaomics), Skyhawk Therapeutics, Inc, Strand Therapeutics Inc., and other Prominent Players.

Key Developments in the Market :
• In Aug 2022, A novel enzymatic mRNA capping solution for the manufacture of mRNA was introduced by New England Biolabs® under the name Faustovirus Capping Enzyme. This new enzyme boosts the capping effectiveness and scalability for mRNA manufacturing workflows, including vaccine production.
• In Jan 2022, Pfizer and BioNTech signed a new global collaboration agreement to work together on developing the first mRNA-based shingles vaccine. Both Pfizer's antigen technology and BioNTech's proprietary mRNA technology will be utilised to develop potential product candidates. It is expected that clinical trials will begin in the second half of the year 2022.
• In Oct 2021, Silence Therapeutics and Hansoh Pharma announced a collaboration to develop therapeutics utilising Silence's mRNAi GOLDTM Platform. The upfront cash payment from Hansoh is expected to be sixteen million dollars, and the possible milestone payments for Silence might be as high as one billion three hundred million dollars.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1185

Market Segmentation:
Global mRNA Synthesis and Manufacturing Services Market, by Type of Industry 2022-2030 (Value US$ Mn)
• Therapeutics and Vaccine Developers
• CDMO Organizations
• Custom Synthesis/Other Service Providers
Global mRNA Synthesis and Manufacturing Services Market, by Applications, 2022-2030 (Value US$ Mn)
• Infectious Disease Vaccines
• Other Vaccines
• Therapeutics and Others
Global mRNA Synthesis and Manufacturing Services Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Research / Preclinical
• Clinical
• Commercial
Global mRNA Synthesis and Manufacturing Services Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global mRNA Synthesis and Manufacturing Services Market
 To receive an industry overview and future trends of the mRNA Synthesis and Manufacturing Services Market
 To analyze mRNA Synthesis and Manufacturing Services Market drivers and challenges
 To get information on the mRNA Synthesis and Manufacturing Services Market size (Value US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the mRNA Synthesis and Manufacturing Services Market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-mrna-synthesis-and-manufacturing-services-market/1185

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Synthesis and Manufacturing Services Market Investment Opportunities and Forecast 2026 to 2035 here

News-ID: 4448218 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Pet Food E-commerce Market Growth Mapping and Forecast Study 2026 to 2035
Pet Food E-commerce Market Growth Mapping and Forecast Study 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pet Food E-commerce Market Size, Share & Trends Analysis Report by Pet Type (Dogs (Dry Food, Wet Food, Snacks/Treats), Cats (Dry Food, Wet Food, Snacks/Treats), Others (Dry Food, Wet Food, Snacks/Treats), by Price Range (Economy, Mid-Range, Premium) Market Outlook And Industry Analysis 2035" Pet Food E-commerce Market Size is valued at USD 20.93 Bn in 2025
Motorcycle Connected Helmet Market Global Demand Analysis and Forecast 2026 to 2035
Motorcycle Connected Helmet Market Global Demand Analysis and Forecast 2026 to 2 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Motorcycle Connected Helmet Market Size, Share & Trends Analysis Report by Type (Full-Face Helmets, Half-Face Helmets, Modular Helmets), by Connectivity Features (Bluetooth Connectivity, GPS Navigation, Music Streaming, SOS Emergency Alert), by Camera Features (Front-Facing Cameras, Rear-Facing Cameras, 360-Degree Cameras), by Sensor Technology (Accelerometers, Gyroscopes, Magnetometers, Barometers) Market Outlook And Industry Analysis 2035" Motorcycle Connected Helmet
OTOF Gene Therapy for Hearing Loss Market Competitive Landscape and Outlook 2026 to 2035
OTOF Gene Therapy for Hearing Loss Market Competitive Landscape and Outlook 2026 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global OTOF Gene Therapy for Hearing Loss Market Size, Share & Trends Analysis Report by Type (Dual AAV Vector-Based, Single AAV Vector-Based, LNP-Based mRNA), by Patient Population (Pediatric (Congenital), Adult (Early Onset), Late-Stage Hearing Loss), by Distribution Channel (Hospital Specialty Clinics, ENT Centers, Rare Disease Treatment Centers),- Market Outlook And Industry Analysis 2035" OTOF Gene Therapy for
AI-Enabled Medical Device Software (AI-DSF) Market Expansion Potential and Revenue Projection 2026 to 2035
AI-Enabled Medical Device Software (AI-DSF) Market Expansion Potential and Reven …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI-Enabled Medical Device Software (AI-DSF) Market Size, Share & Trends Analysis Report by Device Type (Diagnostic Imaging AI, Remote Patient Monitoring, AI-Assisted Surgical Robotics, Clinical Decision Support), by Application (Radiology, Cardiology, Oncology, Neurology), by End User (Hospitals, Diagnostic Labs, Ambulatory Surgical Centers),- Market Outlook And Industry Analysis 2035" AI Enabled Medical Device Software (AI-DSF) Market Size

All 5 Releases


More Releases for RNA

Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a